mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
5.6e-05 |
1 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
5e-18 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
7e-16 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-15 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-13 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
9e-13 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-12 |